Jonathan Wong Still Searching For First Win In Louisiana

Trainer Jonathan Wong, who was hit with a two-year suspension by the Horseracing Integrity and Welfare Unit (HIWU) for a metformin positive, has resurfaced in Louisiana, where he has 15 horses at a private training center but has yet to visit the winner's circle. Wong sent out his first starter in Louisiana on Feb. 13. But the same trainer who had one of the biggest stables in Northern California has struggled there, sending out just five horses without a winner. The plaintiff states of Louisiana and West Virginia won a...

[ Read More ]
Top Mid-Atlantic Trainer Farrior Faces Possible Suspension For Metformin

Trainer Anthony Farrior is facing a possible suspension after a horse he trained allegedly tested positive for the banned substance Metformin, according to a posting Friday on the Horseracing Integrity and Welfare Unit website. His status is listed as "Pending: Provisional Suspension--Postponed." Alexa Ravit, the director of communications & outreach for HIWU explained that the wording means, "that B Sample analysis has been requested following a positive A Sample result, so the implementation of the Provisional Suspension is postponed unless/until the B Sample comes back positive." Farrior will be allowed...

[ Read More ]
Rice Hit With Bute Fine, Suspension; Lodges Appeal Just Before NYSGC To Rule On 'Improper Practices'

Trainer Linda Rice has been suspended 14 days and fined $2,000 by the New York State Gaming Commission after a filly under her care returned a positive test for the non-steroidal anti-inflammatory drug phenylbutazone following a 9 1/2-length win as the 4-5 favorite at Aqueduct Racetrack more than eight months ago. Rice has appealed the Sept. 28 ruling, so she has been granted a stay of those penalties pending a final resolution. The NYSGC also made it public on Friday that Rice will be appearing before the commission for a...

[ Read More ]
HISA Issues Updated Withdrawal Guidance For Phenylbutazone

The Anti-Doping and Medication Control (ADMC) program has proposed enforcing the screening limit of phenylbutazone at 300 ng/mL in blood, rather than the previously established screening limit of 200 ng/mL in blood. HISA will file Guidance with the Federal Trade Commission that will implement this change in the enforcement of the screening limit. The RMTC's Scientific Advisory Committee (SAC) has been asked by industry stakeholders to review its withdrawal guidance of phenylbutazone based upon the updated proposed screening limit. Based on the updated screening limit of 300 ng/mL in blood...

[ Read More ]
Tom Amoss Announces Filly's DQ due to 'Possible Accidental Cross-Contamination'

In a couple of tweets posted to his Twitter account Nov. 13, conditioner Tom Amoss announced that his filly Catwings (Cupid) would be disqualified from her maiden-breaking victory June 23 at Horseshoe Indianapolis due to testing 60 parts per trillion above the threshold of 20 parts per trillion for permissible medication. He did not state what the medication in question was but does include that the stewards reduced his suspension from 15 days to seven after they independently recognized it was a possible case of accidental cross-contamination. Catwings won the...

[ Read More ]

Never miss another story from the TDN

Click Here to sign up for a free subscription.